Winnie Byanyima

New Capabilities

Led UNAIDS special report at AIDS 2026 warning of faltering global HIV response

On Nov. 2, the U.S. Food and Drug Administration gave tentative approval to a generic version of lenacapavir made by India's Dr. Reddy's Laboratories. The twice-yearly shot is expected to sell for about $40 per person per year in 120 low- and middle-income countries. It cannot be sold in the U.S.

Updated 5 days ago

New Capabilities

As of August 2026: Leading the 2030 target push

In 1995, HIV infected about 3 million people in a single year. In 2022 that number fell to 1.3 million, the fewest since the late 1980s.

Updated Aug 5